RAS Function in cancer cells: translating membrane biology and biochemistry into new therapeutics
Keyword(s):
The Past
◽
The three human RAS proteins are mutated and constitutively activated in ∼20% of cancers leading to cell growth and proliferation. For the past three decades, many attempts have been made to inhibit these proteins with little success. Recently; however, multiple methods have emerged to inhibit KRAS, the most prevalently mutated isoform. These methods and the underlying biology will be discussed in this review with a special focus on KRAS-plasma membrane interactions.
Keyword(s):
Keyword(s):
2019 ◽
Vol 19
(23)
◽
pp. 2114-2127
◽
2017 ◽
Keyword(s):
2013 ◽